找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cosmetics; Controlled Efficacy P. Elsner,Howard I. Maibach (Professor),Hans F. Me Book 1999 Springer-Verlag Berlin Heidelberg 1999 ageing.

[復制鏈接]
樓主: 要求
41#
發(fā)表于 2025-3-28 16:10:00 | 只看該作者
Ruth McNerlan,Yaxin Bi,Guoze Zhao,Bing Han We will provide here information about the PAL, especially about those regulations related to efficacy claims for cosmetics (We use the term of efficacy simply here; however, it can also denote clinical effectiveness, usefulness and even product claims).
42#
發(fā)表于 2025-3-28 21:45:22 | 只看該作者
43#
發(fā)表于 2025-3-28 23:18:31 | 只看該作者
44#
發(fā)表于 2025-3-29 04:43:45 | 只看該作者
45#
發(fā)表于 2025-3-29 10:43:07 | 只看該作者
to Article 7b, special claims of efficacy could be legally attributed to cosmetic products but under the obligation to make evidence of the claimed effects; also an entirely new "controller" was introduced - the independent "safety assessor", This indeed means not only progress in reliable and hones
46#
發(fā)表于 2025-3-29 15:05:48 | 只看該作者
Michael Crowhurst,Michael Emslieons for its use and disposal as well as any other indication or information provided by the manufacturer or his authorized agent or by any other person responsible for placing the product on the Community market” [1].
47#
發(fā)表于 2025-3-29 16:29:39 | 只看該作者
Zhiwei Luo,Rong Xie,Wangyi Huang,Yiwei Shann Europe, for example, the European Cosmetic Directive requires that products have documentation to support the claims made [1]. In the United States the requirement is essentially the same except that some products that are considered cosmetic in some regulatory jurisdictions are over-the-counter drug products in the United States.
48#
發(fā)表于 2025-3-29 20:16:32 | 只看該作者
Siegfried Bodenmann,Anne-Lise Reyributed to wider use. As available products have proliferated in the marketplace, claims regarding performance and efficacy of self-tanning lotions have been refined and broadened for promotion to an enlarging consumer base.
49#
發(fā)表于 2025-3-30 00:11:46 | 只看該作者
50#
發(fā)表于 2025-3-30 07:38:35 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 13:05
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
乌拉特后旗| 运城市| 武冈市| 客服| 定安县| 太仓市| 任丘市| 临湘市| 石林| 九寨沟县| 呼伦贝尔市| 苏尼特右旗| 马边| 栖霞市| 玛曲县| 鹤峰县| 班戈县| 石景山区| 永新县| 道真| 榆树市| 弥渡县| 泾阳县| 布尔津县| 西乌珠穆沁旗| 弥渡县| 德江县| 黄陵县| 新闻| 绥芬河市| 黔西县| 瑞丽市| 通榆县| 睢宁县| 巴彦淖尔市| 江川县| 东方市| 仙游县| 辉南县| 龙口市| 石嘴山市|